Celsius is a Massachusetts-based biotechnology company that researches and develops RNA-based therapeutics for the treatment of inflammatory diseases.
$83M
Mar 23, 2022
-
InterVenn is a California-based AI glycoproteomics platform that offers solutions such as biomarker research and liquid biopsy assay development for the healthcare industry.
$201M
Aug 01, 2021
-
Digital Diagnostics is an Iowa-based AI diagnostic platform that offers solutions such as image analysis and EMR integration for the healthcare industry.
$15M
May 28, 2020
-
RubiconMD is a New York-based E-consult platform that allows primary care providers to connect with specialists for medical guidance and opinions.
$18M
Feb 06, 2020
-
Aitia is a Massachusetts-based AI-enabled biotech company that captures genetic and molecular interactions that causally drive clinical and physiological outcomes.
$5M
Jan 06, 2020
-
Frequently Asked Questions about HPN
What is HPN investing in?
HPN has invested in 13 companies including Celsius Therapeutics, InterVenn and Digital Diagnostics
What company did HPN invest in?
HPN invested in a total 13 companies including Celsius Therapeutics, InterVenn and Digital Diagnostics
What are the top 5 investments by HPN?
The top companies in which HPN invested are Celsius Therapeutics, InterVenn, Digital Diagnostics, RubiconMD and Aitia
